Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 19 July 1996:
Vol. 273. no. 5273, pp. 302 - 303
DOI: 10.1126/science.273.5273.302a
Prev | Table of Contents | Next

News & Comment

Jon Cohen

Vancouver, British Columbia--Recent advances in drug therapies for AIDS got the bulk of the public attention at the 11th International Conference on AIDS here. But equally interesting to the attendees were the latest findings on the inflammatory proteins called chemokines and their receptors. The reason: recent work showing that a particular chemokine receptor is needed for HIV infection, at least of cells in culture, and that certain chemokines may block that infection. Still, the meeting also revealed an intellectual rift between leading AIDS researchers about whether the chemokine work will ever bring improved HIV treatments or vaccines.




To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)